Synthesis of 3,3-d2-D-cysteine.
According to Shiraiwa's procedure, [1] DLcysteine (3,3-d 2 ) (2.06 mmol) and ammonium chloride (2.06 mmol) were recrystallized from water. The pH was adjusted to 6 to obtain the DL-cysteine hydrochloride salt in situ. A mixture of the obtained salt, acetone (10.4 mmol), salicylaldehyde (0.020 mmol) and tartaric acid (2.06 mmol) in 0.52 mL of acetic acid was then heated at reflux for 7 h. The mixture was stirred on ice for 30 min. The formed precipitate was filtered off and washed with diethyl ether. The salt was hydrolyzed with 0.5 mL of water in 5 mL of ethanol at 60 °C to obtain the crude cysteine product (58.4% yield). The crude product was then washed with 1.5 mL of methanol to give 121 mg (48% yield) of optically pure product. [ HPLC analysis of luciferin and analogues. Commercial dehydroluciferin was from Regis Technologies for use as a chromatographic reference. A solution of 90 µM of a luciferin (20 µL) was manually injected onto an Econosil C18 (Alltech) RP-HPLC column. The eluent was 10% acetonitrile/90% water, isocratic, flowing at 1 mL min -1 . The chromatograms and corresponding UV-vis spectra were analyzed by an Agilent Chemstation to verify the purity of commercial dehydroluciferin and synthesized luciferin and d 2 -luciferin.
General biochemical methods. Materials. Luciferase from firefly (Photinus pyralis) was expressed and purified from BL21(DE3) E. coli cells transformed with a pET28(b+)-WTLuc vector, following methods reported by Liao et al. [3] Concentrations of luciferase stock solutions were determined before each experiment using a NanoDrop 2000 spectrophotometer based on the extinction S3 coefficient at 278 nm of 45.6 (mM•cm) -1 . Purified luciferase was concentrated using a Microcon® (EMD Millipore) ultrafiltration membrane with a 30 kDa cutoff for experiments that required high enzyme concentration. Enzyme diluent composed of BSA (1 mg/ml) and Tris-HCL pH 7.8 (20 mM) was used to dilute luciferase to the desired concentrations. All water for buffers, solutions and to perform experiments was obtained from a water purification system and showed 18 megohm-cm resistance. MOPS buffer (3-(N-morpholino)propanesulfonic acid) was from Fisher Scientific. Horseradish peroxidase (HRP) and Amplex Red were from Thermo Scientific. MOPS stock solutions were made at 1 M and stored at room temperature; working solutions of 0.5 M were made at pH 7.0 by adjusting the pH using sodium hydroxide solution. ATP was from RPI Corp., stock solutions were made at 0.1 M, and they were kept at -20 °C until use. Stock solutions of each luciferin were prepared by dissolving the free acid in water. To assist dissolution, stocks were placed in an ultrasonic bath for 10 to 15 min or until no particles were visible. Concentrations of stock solutions of luciferin and d 2 -luciferin were determined using the extinction coefficient of 18.2 (mM•cm) -1 at 328 nm.
Bioluminescence assay. Reactions were prepared in triplicate for each substrate concentration in a final volume of 220 µL. Each reaction includes luciferin (34 µM), ATP (1.7 mM) and MgSO 4 (11 mM) in MOPS (68 mM, pH 7.0). Reaction were started by manually adding 30 µL of 0.08 µM luciferase in enzyme diluent. Emission readings began 10 s after adding enzyme and photons were measured every 30 s for 15 min with an integration time of 1 s. Bioluminescence was measured on Synergy Mx BioTek® plate reader in white 96-well plates. Data analysis for enzyme kinetics was performed and plotted using GraphPad Prism 5 software.
Isotope effect on dehydroluciferin formation. Dehydroluciferin and oxyluciferin produced in luciferase reactions were quantified by the RP-HPLC method of Da Silva et al. using a mobile phase of 70% phosphate buffer (pH 7.0) and 30% methanol, [4, 5, 6] modified to decrease the oxyluciferin retention time. After luciferin and dehydroluciferin elute (10 min), methanol was increased from 30% to 85% and the flow rate was increased from 1 to 1.3 mL/min. A concentration curve at concentrations from 0.01 to 1 µM was developed for dehydroluciferin using a commercial sample. Quantification of oxyluciferin was based on the known ratio of dehydroluciferin:oxyluciferin of 1:4 in luciferin/luciferase reactions and applying the response factor from those experiments to those with d 2 -luciferin. It was established prior to analysis of reaction mixtures that the components present in luciferase reactions (cofactors and enzyme) do not interfere with the RP-HPLC analysis of dehydroluciferin and oxyluciferin.
Large reaction volumes and high concentrations of luciferase and substrate were used to give sufficient quantities of dehydroluciferin and oxyluciferin for consistent analysis. Luciferase reaction mixtures were prepared in Eppendorf tubes with substrate (50 µM), ATP (1.5 mM), MgSO 4 (2 mM), and MOPS buffer (pH 7.0, 60 mM) in a 500 µL final volume. Before each run, purified luciferase stock (300 µL) was added to a Microcon® filter and centrifuged at 10,000 rpm at 4 °C for 30 min. The enzyme concentration attained was determined by absorbance and reactions were initiated by adding luciferase to make a final concentration of 20 µM. Reactions proceeded for 1.5 h at room temperature and were stopped by adding EDTA (60 µL of 300 mM). Reaction tubes were vortexed briefly and centrifuged for 1 min at 14,000 rpm. The supernatant was analyzed by RP-HPLC (200 µL per injection). Reactions were performed in triplicate and each reaction was analyzed twice by RP-HPLC. Data on the molar quantities of products are collected in Table S1 . The isotope effect is calculated from the ratio of the oxyluciferin/dehydroluciferin ratios with protonated and deuterated substrates. Table S1 . Dehydroluciferin and oxyluciferin production by firefly luciferase reactions with luciferin and d2-luciferin as substrates. Isotope effect on hydrogen peroxide formation. Hydrogen peroxide produced in luciferase reactions was measured using the method applied by Da Silva et al., horseradish peroxidase (HRP)-based resorufin formation (Amplex® Red reagent). [7] A calibration curve from 0.02-2.0 nmoles of hydrogen peroxide was developed for the Amplex Red assay. Luciferase reactions were performed for 2 h and stopped as for the RP-HPLC analysis above. Reactions contained luciferase (20 µM), luciferin or d 2 -luciferin (50 µM), ATP (1.5 mM), MgSO 4 (2 mM), and MOPS buffer (pH 7, 60 mM). After stopping the reaction, the remainder of the experiment was performed in a darkroom to avoid photooxidation of Amplex® Red to resorufin by light. [8] Assay stock solutions were prepared fresh before each experiment by adding 20 µL of 20 mM Amplex Red stock in DMSO and 14 µL of HRP (freshly resuspended in 1 mM PBS to 1 mg/mL, 72 U/mL) to 966 µL1 mM PBS. Luciferase reaction mixture (100 µL) was added to a 96 black-well plate containing 100 µL of the Amplex Red/HRP reaction mix to final concentrations of 0.2 mM and 0.5 U/mL, respectively. After 30 min incubation at room temperature, the fluorescence of resorufin was measured (λ ex 530 nm, λ em 590 nm). Reactions were run in triplicate and each reaction was assayed for hydrogen peroxide in duplicate. Data are collected in Table S2 . The isotope effect is calculated simply from the ratio of the nmoles of hydrogen peroxide with protonated and deuterated substrates. Table S2 . Hydrogen peroxide production by firefly luciferase reactions with luciferin and d2-luciferin as substrates. Hydrogen peroxide (in nmol) determined in three luciferase bioluminescence reactions and duplicate fluorescence analyses of each reaction. The first 3 rows show the mean and SD of the duplicate analyses per reaction and the last row shows the mean and SD of those 3 reactions. The H 2 O 2 quantities were determined from a calibration curve.
